Maganin Farfado da Kasusuwa
Hematology
Daga
$1,500
Har zuwa $8,000 ya danganta da cibiya
Tsawon lokaci na yau da kullum
3–10 days
Hada da gwaje-gwajen kafin tiyata
An bincika wannan abun ciki don daidaiton likitanci daga: Dr. Rodina Ainasoa · Marubuciyar Likitanci & Sadarwar Lafiya
Bayyani
Samun damar jiyya ta sabuntawa bisa shaida — ciki har da allurai na PRP da jiyya ta sel na shina na mesenchymal — don lalacewar gabbai, lalacewar kwalba, da raunin tendon a cibiyoyi da aka amince ta kasa da kasa. Majinyata suna amfana daga kulawa bisa biologics mafi sabin fasaha da ƙaramin farashi, tare da ɗan gajeren lokacin jira da goyon bayan gyarawa na musamman.
Ana daidaita al'amarinku da cibiya bisa bayanan sakamako na likitanci, ba talla ba. Muna tsara kowane mataki — daga gwaje-gwajen kafin tiyata zuwa biye-biye bayan jiyya — tare da mai tsara kulawa na musamman.
Abinda ya hada
Maganin Farfado da Kasusuwa
Kimar farashin hadin kai daga
ko aiko mana sako a kan WhatsApp
Ba a bukatar alkawari. Ana raba bayananku ne kawai da jam'iyyun da aka amince da su wadanda ke da hannu a hadin kan kulawar ku, bisa ka'idojin sirri da suka shafi.
Manyan bayanai a takaice
Daga
$1,500
Har zuwa $8,000 ya danganta da cibiya
Tsawon lokaci na yau da kullum
3–10 days
Hada da gwaje-gwajen kafin tiyata
Hanyoyi
4
Riƙe don ganin hanyoyi
Asibitocin hadin gwiwa
0
An duba su don bayanan sakamako da takardar shaida
Allurar PRP da Prolotherapy don Yanayin Kasusuwa
Allurar plasma mai wadataccen platelet (PRP) da prolotherapy sune hanyoyin allura na maido-da-jiki guda biyu da aka fi amfani da su don yanayin jijiyoyin tsoka, ligament, da gaɓoɓi. Wanne daga cikinsu, idan akwai, ya dace da wani yanayi ya dogara ne akan takamaiman ganewar asali da shaidar da aka buga game da wannan yanayin — ba wata dabara ta gama-gari cewa kowace hanya tana taimakawa duk yanayi ba, kamar yadda American Academy of Orthopaedic Surgeons (AAOS) ta bayyana.
| Sigar | Allurar PRP | Prolotherapy |
|---|---|---|
| Abin da ake allura | Tarin da aka shirya daga jinin mai haƙuri, wanda ke ɗauke da platelets da abubuwan haɓaka, kamar yadda Mayo Clinic da Cleveland Clinic suka bayyana. | Wani ruwa mai motsa jiki, galibi dextrose, ana yin masa allura a ciki da kewayen wurin da jijiyar tsoka ko ligament ta haɗe don kawo martanin warkarwa na gida, kamar yadda AAOS ta bayyana. |
| Yawan zaman da ake yi a al'ada | Sau da yawa allura ɗaya zuwa uku da aka raba ta makonni da yawa, ya danganta da yanayin da kuma ka'idar asibiti. | Yawanci jerin allura uku zuwa shida da aka raba ta makonni biyu zuwa shida, kamar yadda tsare-tsaren prolotherapy da aka buga suka bayyana. |
| Ƙarfin shaida (ciwon gwiwa na osteoarthritis, a matsayin misali) | Bincike-bincike masu tsari da tarin bincike sun ba da rahoton ci gaba mai muhimmanci a asibiti na ciwo da aiki idan aka kwatanta da placebo cikin watanni 3-12, tare da wasu shaidu na ci gaba mafi kyau na aiki idan aka kwatanta da hyaluronic acid — ko da yake tsare-tsaren shirye-shirye sun bambanta sosai a tsakanin bincike, kamar yadda ilimin da aka bita ya bayyana. | Shaida don ciwon gwiwa ta fi iyaka fiye da ta PRP, tare da ƙarancin gwaje-gwajen bazuwar masu inganci; wasu bincike sun nuna fa'ida amma sakamako ba su da daidaito sosai, kamar yadda ilimin da aka bita ya bayyana. |
| Ƙarfin shaida (lateral epicondylitis / tennis elbow, a matsayin misali) | Gwaje-gwaje na bazuwar sun ba da rahoton sauƙin ciwo na dogon lokaci da murmurewar aiki mafi kyau idan aka kwatanta da kulawa ta al'ada, ko da yake kwatance da wasu jiyya masu aiki sun bambanta ta hanyar bincike, kamar yadda ilimin da aka bita ya bayyana. | Gwaje-gwajen asibiti sun nuna prolotherapy zaɓi ne mai tasiri amma ba su nuna daidaito na fifikonta akan physiotherapy ko wasu jiyya masu aiki don wannan yanayin ba, kamar yadda ilimin da aka bita ya bayyana. |
| Matsayin hukuma | PRP har yanzu amfani ne na gwaji da ba a tabbatar ba a fannoni da yawa kuma ba FDA ta amince da shi ba musamman don osteoarthritis, don haka sau da yawa inshora ba ta rufe shi ba, kamar yadda AAOS ta bayyana. | Ruwan prolotherapy magunguna ne da ake samu a al'ada da ake amfani da su ba bisa izini ba don wannan manufa; kula da hukuma na dabarar allurar da kanta ya bambanta da ƙasa, kamar yadda AAOS ta bayyana. |
Hanyar Magani: Mataki-Mataki
Matakan da ke ƙasa suna bayyana yadda ake yin jerin allurar PRP ko prolotherapy don yanayin kasusuwa a al'ada. Gwanin ku zai tabbatar da wace hanya, idan akwai, take da tallafin shaida don takamaiman ganewar asalinku.
Hoton ganewar asali da zaɓen mai haƙuri
Gwani yana bitar tarihinku, sakamakon gwaji, da hoto (kamar ultrasound ko MRI) don tabbatar da ganewar asali da kuma tantance ko shaidar da aka buga tana tallafawa PRP ko prolotherapy don takamaiman yanayinku, kamar yadda AAOS da Mayo Clinic suka bayyana.
Ɗaukar jini da shirya PRP (inda ake amfani da PRP)
Don PRP, ana ɗaukar ƙaramin samfurin jinin mai haƙuri kuma ana sarrafa shi a cikin centrifuge don tattara platelets da abubuwan haɓaka a cikin shirye-shiryen alluran; a maimakon haka, prolotherapy tana amfani da ruwa mai motsa jiki da aka riga aka gauraya, don haka wannan matakin ba ya aiki ga wannan hanyar.
Allura da hoto ke jagoranta
Ana yin allurar shirin PRP ko ruwan prolotherapy zuwa cikin jijiyar tsoka, ligament, ko gaɓar da aka nufa, yawanci ƙarƙashin jagorancin ultrasound don inganta daidaiton sanyawa, kamar yadda Cleveland Clinic ta bayyana.
Tsari da sa ido bayan allura
Ana sa ido kan marasa lafiya na ɗan gajeren lokaci bayan allura kuma ana ba su jagorar ayyuka na kwanaki masu zuwa; saboda ana buƙatar jerin allura sau da yawa, gwani yana tsara zaman bibiya kuma yana sake tantance martani kafin maimaita magani.
Jadawalin Murmurewa
Ciwo na ɗan lokaci, kumburi, ko taurin jiki a wurin allura al'ada ne kuma yawanci yana warwarewa cikin kwanaki kaɗan; wannan martani ne da ake tsammani kuma an tabbatar da shi sosai, ba alamar gazawar magani ba, kamar yadda AAOS da Mayo Clinic suka bayyana.
Duk wani ci gaba na farko, idan ya faru, yakan zama a hankali maimakon nan take; yawancin tsare-tsare suna haɗa da ƙarin allura a wannan lokacin maimakon magani guda ɗaya kawai.
Idan martanin magani ya faru, bincike-bincike da aka buga sun ba da rahoton ci gaba mai muhimmanci a asibiti na ciwo da aiki wanda ke ƙara bayyana daga wannan matakin har zuwa watanni da yawa na bibiya; martani ba a tabbatar da shi ba kuma ya bambanta da yanayi da mutum, kamar yadda ilimin da aka bita ya bayyana.
Sakamako na dogon lokaci na ci gaba da bincike kuma sun bambanta sosai tsakanin yanayi da mutane; marasa lafiya ya kamata su tattauna tsammanin gaskiya, na musamman ga yanayinsu, tare da gwaninsu maimakon ɗaukar cewa akwai jadawalin murmurewa da ba ya canzawa, kamar yadda AAOS ta bayyana.
Tushen: American Academy of Orthopaedic Surgeons (AAOS); Mayo Clinic; Cleveland Clinic; bincike-bincike masu tsari da aka bita game da PRP da prolotherapy. Murmurewa da sakamako na mutum ɗaya sun bambanta kuma ba a tabbatar da su ba.
Haɗari da Iyakoki da Aka Sani
- Ingancin shaida ya bambanta sosai bisa yanayin da aka ambata — wasu alamomi, kamar ciwon gwiwa na osteoarthritis da wasu tendinopathies, suna da adadi mai kyau kuma mai girma na bayanan gwaji, yayin da don sauran yanayi da yawa da asibitoci ke tallatawa, shaida ta kasance iyakacce ko marar daidaito, kamar yadda AAOS da ilimin da aka bita suka bayyana.
- Ci gaba ba a tabbatar da shi ba, kuma idan ya faru yakan kasance a hankali kuma na wani sashi maimakon warkarwa gaba ɗaya; PRP da prolotherapy ba maye gurbin tiyata ba ne a lokutan da tiyata ta zama dole a asibiti, kamar yadda AAOS ta bayyana.
- Haɗarin allura na yau da kullum suna aiki, gami da kamuwa da cuta a wurin allura, tashin ciwo na ɗan lokaci, cizawar jini, da yiwuwar rashin samun ci gaba mai muhimmanci duk da magani, kamar yadda Mayo Clinic da Cleveland Clinic suka bayyana.
- Saboda tsare-tsaren shirya PRP (yawan platelet, adadin leukocyte, hanyar kunnawa) sun bambanta sosai tsakanin asibitoci kuma ba a daidaita su ba, sakamakon da aka ruwaito a wani bincike ko asibiti na iya rashin dacewa kai tsaye da wani, kamar yadda ilimin da aka bita ya bayyana.
- Marasa lafiya ya kamata su nemi cibiyoyin magani da suke bayyana a fili game da shaidar da aka buga ta musamman ga yanayinsu da sakamako na gaskiya da ake tsammani ga takamaiman ganewar asalinsu, maimakon ikirari na gaba ɗaya cewa allurar maido-da-jiki na iya maido ko gyara duk wata matsalar gaɓa ko nama, kamar yadda jagorar marasa lafiya ta AAOS ta bayyana.
Tushen: American Academy of Orthopaedic Surgeons (AAOS); Mayo Clinic; Cleveland Clinic; bincike-bincike masu tsari da aka bita. Babu wani tsari da ba shi da haɗari, kuma shaida don wannan nau'in magani ta bambanta sosai bisa yanayi; gwaninku zai duba yanayinku na musamman.
Hanyar Kulawa ta CureSureMedico
Bitar asibiti ta nesa
Raba ganewar asalinku, hoto, da tarihin magani na baya tare da ƙungiyar tsara mu, waɗanda ke tura shari'arku don farkon tantancewar gwani game da ko shaidar da aka buga tana tallafawa PRP ko prolotherapy don takamaiman yanayinku.
Haɗa da asibiti bisa shaida
Muna haɗa ku da cibiyar kasusuwa da aka amince da ita mai gogewa a takamaiman yanayinku da dabarar allura, wanda aka tabbatar da shi bisa tushen shaidar da aka buga maimakon ikirarin talla na gaba ɗaya.
Ƙiyasin kuɗi da tsara zaman
Muna ba da ƙiyasin kuɗi mai haɗa kai wanda ya haɗa da shawara, bitar hoto, da yawan zaman allura da ake tsammani, kuma muna taimaka muku tsara tsawon tafiya wanda ya yi la'akari da yiwuwar buƙatar zaman da yawa.
Magani da sa ido
Kuna halartar zaman/zaman alluranku ƙarƙashin jagorancin hoto, tare da sa ido bayan allura da jagorar ayyuka daga ƙungiyar kula da ku a duk lokacin zamanku.
Bibiya da ci gaba da kulawa
Kafin ka tafi, ana raba rikodin maganinku da jadawalin bibiya na gaskiya tare da likitanku na gida don ya iya bibiyar martaninku da tsara ƙarin zaman idan ana buƙata.
Kwatancen farashi na duniya — Maganin Farfado da Kasusuwa
Matsakaicin farashi da aka tsara a fadin cibiyoyinmu na hadin gwiwa. Farashin karshe ya danganta da tsananin yanayi da asibitin da aka zaba.
| Kasa | Matsakaicin farashi | idan aka kwatanta da mafi araha |
|---|---|---|
🇮🇳 India New Delhi · Chennai · Bengaluru · Hyderabad · Mumbai · Kochi | $2,000 | —chevron_right |
🇹🇷 Turkey Istanbul | $4,000 | +100%chevron_right |
Farashi kimantawa ne kuma yana bambanta bisa ga cikakkun bayanan aikin, asibiti, da tsananin yanayin likita. Nemi kimar musamman don al'amarinku.
Hanyoyin Da Suka Yi Kama
Maganin Sel Iri (Stem Cell)
Amfani da sel na shina wajen jiyya — haematopoietic, mesenchymal, ko induced pluripotent — don gyarawa, sabuntawa, ko maye gurbin nama mai lalace a cututtukan jini, yanayin degenerative, da wasu cututtukan autoimmune da aka zaɓa.
Daga
$3,000
kwana 14–60
Maganin Leukemia, Lymphoma da Kansar Jini
Samun damar manyan cibiyoyin hematology-oncology masu ba da chemotherapy, jiyya ta targeted, immunotherapy, da jiyya ta sel ta CAR T don leukemia, Hodgkin lymphoma, non-Hodgkin lymphoma, da sauran cututtukan jini. Indiya da Isra'ila an san su a duniya don ƙwarewa ta hematology, suna ba da cibiyoyi da aka amince da JCI da farashi mai raguwa sosai idan aka kwatanta da kasashen Yamma.
Daga
$12,000
kwana 21–90
Maganin Sickle Cell da Thalassemia
Nemo jiyya mai waraka don cutar sickle cell da thalassemia mai girma ta hanyar dashen ƙudan ƙashi, kazalika da sarrafa cuta ƙwararru ciki har da jiyya ta hydroxyurea, shirye-shiryen zub da jini, da chelation. Manyan cibiyoyin hematology a Indiya suna ba da BMT na ɗan'uwan da ya dace da haploidentical don waɗannan matsalolin jini na gado da ƙaramin farashi.
Daga
$15,000
kwana 60–120
Maganin Karancin Jini na Aplastic
Karɓar jiyya mai yuwuwar waraka don aplastic anemia mai tsanani ta hanyar dashen ƙudan ƙashi ko jiyya ta immunosuppressive mai tasiri sosai (IST) tare da anti-thymocyte globulin da cyclosporine. Indiya da Isra'ila suna ba da shirye-shiryen aplastic anemia na ƙargin duniya tare da likitocin hematologist ƙwararru da farashi mai ƙarƙashin farashin Yamma da kashi 60-80%.
Daga
$15,000
kwana 45–100
Tambayoyin da ake yawan yi
Most patients require 1–3 injection sessions depending on the severity of joint damage. PRP typically shows gradual improvement over 4–12 weeks as the platelet growth factors stimulate tissue repair. Mesenchymal stem cell therapy may produce earlier functional gains, with many patients reporting reduced pain and improved mobility within 6–8 weeks. Your orthopaedic specialist will recommend the optimal protocol after reviewing your imaging and clinical history.
Kudi bayyananne. Babu alkawari.
Jagora mai bayyana da gaskiya
CureSureMedico tana karɓar kuɗin tsari bayyananne kuma tsayayye daga majinyaci ko cibiyar biyan kuɗi. Asibiti abokin tarayya ne ke karɓar kuɗin jiyya kai tsaye.